Recently, the fluorescent quantitative PCR instrument (ND360)developed by“JanMa gene” has obtained CE certification, which marks that the nucleic acid detection system of JanMa gene has been recognized by developed countries in Europe and has obtained overseas sales qualification.
Since the outbreak of COVID-19 in the world since 2020, the World Health Organization and other countries recommend the PCR detection of SARS-CoV-2 as the diagnostic standard, which results in the shortage of fluorescent quantitative PCR instruments. The company has taken the lead in the development of “national gene detection community” and “make every effort to improve the capability of real-time detection and detection of human destiny”.
Nd360 is a product under the company’s products > device >Quantitative Real-time PCR. The instrument has built-in dual module and dual channel design, single module can run independently, and the detection efficiency is doubled. The sars-cov-2 nucleic acid detection kit and rapid extraction reagent developed independently by the company can complete from “sample” to “result” in 35 minutes, greatly improving the detection efficiency.
The instrument uses semiconductor refrigeration technology to quickly realize PCR amplification, real-time detection of fluorescence signal through highly sensitive photoelectric detection system, and analysis and processing through powerful analysis software. It is compatible with common nucleic acid detection kits in the market. Win10 operating system, simple operation, small size, light weight, easy to carry, easy to assist nucleic acid detection test.
Post time: Dec-03-2020
